Smartphone App Improves Kidney Transplant Outcomes
FRIDAY, May 14, 2021 -- A pharmacist-led smartphone health app prevents medication errors and hospitalizations among kidney transplant recipients, according to a study published in the May issue of the Clinical Journal of the American Society of Nephrology.
Haley M. Gonzales, Pharm.D., from the Medical University of South Carolina in Charleston, and colleagues evaluated the efficacy of improving medication safety through a pharmacist-led, mobile health-based intervention. Adult kidney recipients (136 patients; six to 36 months posttransplant) were randomly assigned to an intervention (supplemental clinical pharmacist-led medication therapy monitoring and management via a mobile health-based application, integrated with risk-guided televisits and home-based blood pressure and glucose monitoring) or usual care.
The researchers found that participants receiving the intervention experienced a significant reduction in medication errors (incident risk ratio, 0.39) and a significantly lower incidence risk for grade 3 or higher adverse events (incident risk ratio, 0.55). The intervention arm also showed significantly lower rates of hospitalizations (incident risk ratio, 0.46).
"It is paramount that we identify innovative strategies to help manage medication safety issues, and the integration of mobile health-based interventions and clinical pharmacist leadership represents a promising opportunity," a coauthor said in a statement.
Two authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted May 2021
Read this next
FRIDAY, June 18, 2021 -- Many patients with top 20 percent Estimated Post-Transplant Survival (EPTS) are not waitlisted for kidney transplant, according to a study published...
FRIDAY, June 11, 2021 -- Most hemodialysis patients (HDP) but few kidney transplant recipients (KTRs) develop antibody responses to severe acute respiratory syndrome coronavirus 2...
MONDAY, June 7, 2021 -- A total of 8.7 to 12.9 excess deaths were estimated per 1,000 end-stage renal disease (ESRD) patients during the early stage of the COVID-19 pandemic...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.